Metabomed's Series A Round

Metabomed raised a round of funding on April 04, 2016.

Metabomed is a drug discovery company in the field of cancer metabolism with a proprietary target identification platform based on computational biology and metabolomics. Metabomed focuses on the disc…

Articles about Metabomed's Series A Round: